United States · FDA National Drug Code directory
Fingolimod
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-476_d2f337fa-908a-4ae9-bcfd-59dcc4353705
- Product NDC
- 67877-476
- Form
- CAPSULE
- Composition / generic term
- Fingolimod hydrochloride
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220921
- Source listing expiry
- 20271231
Source-listed ingredients
- FINGOLIMOD HYDROCHLORIDE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (67877-476-30) · 67877-476-30
- 7 BLISTER PACK in 1 CARTON (67877-476-32) / 7 CAPSULE in 1 BLISTER PACK · 67877-476-32
- 10 BLISTER PACK in 1 CARTON (67877-476-33) / 10 CAPSULE in 1 BLISTER PACK · 67877-476-33
- 28 CAPSULE in 1 BOTTLE (67877-476-56) · 67877-476-56
- 28 BLISTER PACK in 1 CARTON (67877-476-58) / 14 CAPSULE in 1 BLISTER PACK (67877-476-14) · 67877-476-58
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →